Texas Oncology- Medical City Dallas Building D

7777 Forest Lane
Dallas, Texas 75230

We've found

1 trials

at this facility

ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Dallas, TX

Use our guide to learn which trials are right for you!